Paul Tudor Jones 10x Genomics, Inc. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 81,612 shares of TXG stock, worth $1.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
81,612
Previous 63,892
27.73%
Holding current value
$1.6 Million
Previous $3.58 Million
14.35%
% of portfolio
0.02%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding TXG
# of Institutions
309Shares Held
92MCall Options Held
267KPut Options Held
62.1K-
Vanguard Group Inc Valley Forge, PA9.1MShares$178 Million0.01% of portfolio
-
Baillie Gifford & CO7.42MShares$145 Million0.22% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.28MShares$123 Million1.68% of portfolio
-
Black Rock Inc. New York, NY6.01MShares$118 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.16MShares$101 Million0.02% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.86B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...